Discover Brainport Eindhoven

In the technology region of Brainport Eindhoven, we work intelligently together as thinkers and doers. The possibilities are endless within Brainport. Discover, learn and grow.

What is Brainport Eindhoven?

Innovation, technology and entrepreneurship

The strategy

Brainport Development

PSV & Brainport Eindhoven

Close Close

Brainport for you

Whether you are studying, working or having a company here, Brainport Eindhoven offers limitless opportunities for growth. Your success depends on the way you overcome your challenges. Please contact Brainport if you need any support. We will help you gain more knowledge and new perspectives or we will just answer your questions.

Entrepreneurs

Professionals

Students

Close Close
Close Close

Seed investment by LUMO Labs for health tech venture AlphaBeats

The Eindhoven based startup combines biofeedback technology with music to drastically reduce the effects of stress.

 

The Eindhoven based startup combines biofeedback technology with music to drastically reduce the effects of stress.

 

Written by Innovation Origins

18 December 2020

Thanks for your subscription.


LUMO Labs, the early-stage investment fund, announces an investment in the health tech startup AlphaBeats. The money involved was not disclosed. The startup has exclusive rights to a technology developed by Philips that combines biofeedback technology with music to drastically reduce the effects of stress.

AlphaBeats will join the LUMO Labs two-year venture builder program and use this new investment round for a market validation with the goal to be on the market in 18 months.

“In addition to seeking a financial return for our investors, we invest in startups that have substantial social impact. It would be great if we can realize this,” said LUMO Labs Founding Partner Andy Lürling. “As stress is considered the health epidemic of the 21​ century, we contribute by investing in AlphaBeats. It fits perfectly in our health and well-being focus.”

AlphaBeats has the sole, exclusive agreement with Philips to use the company’s audio neurofeedback algorithm. That algorithm, combined with artificial intelligence, uses biofeedback signals to enhance the user’s favorite music.

“We all know music has a powerful effect on the mind. Many people already use it to relax and unwind, to cope with the turbo-speed of life. With AlphaBeats, we multiply that effect,” said AlphaBeats CEO Han Dirkx. “Using AI, our solution is three times more effective than listening to your favorite music alone, and after four weeks, a person’s ability to relax dramatically improves.”

A strategic collaboration enables the Dutch AlphaBeats team to measure heart rate variability on a cell phone in addition to breathing. “AlphaBeats uses this to analyze your real-time brain activity,” explains CMO, co-founder, and surgeon Dr. Jur Vellema. “The patented algorithm then adjusts your favorite music to bring your brain into a relaxed state: alpha mode. This adjustment is done very subtly to prevent users from being annoyed by the changes in their favorite music. And best of all, you don’t necessarily have to invest in a nice wearable one. You can just use your cell phone and headphones. This means we don’t have to develop any hardware ourselves.”

AlphaBeats was founded in 2019 as part of HighTechXL’s deep-tech venture builder program. “Our collaboration with LUMO Labs on AlphaBeats is a great example of connecting the innovation chain for startups in the Brainport region,” said HighTechXL CEO John Bell. “HighTechXL builds deep-tech ventures that solve societal challenges, whereas LUMO Labs takes over the baton from us and develops AlphaBeats further on its growth curve. The strengths and networks of LUMO Labs and HighTechXL complement each other, therefore we expect to see more collaboration with LUMO Labs in the future.”